FFA
RYTM icon

Farther Finance Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

Farther Finance Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$62.8K Buy
660
+7
+1% +$747 ﹤0.01% 3222
2026
Q2 		$72.5K Buy
653
+8
+1% +$723 ﹤0.01% 2953
2026
Q1 		$56.8K Buy
645
+3
+0.5% +$292 ﹤0.01% 2903
2025
Q4 		$68.7K Buy
642
+291
+83% +$30.9K ﹤0.01% 2598
2025
Q3 		$35.4K Buy
351
+322
+1,110% +$29.9K ﹤0.01% 2652
2025
Q2 		$1.83K Buy
29
+15
+107% +$918 ﹤0.01% 3730
2025
Q1 		$700 Hold
14
– – ﹤0.01% 3709
2024
Q4 		$784 Hold
14
– – ﹤0.01% 3325
2024
Q3 		$733 Buy
14
+5
+56% +$240 ﹤0.01% 3326
2024
Q2 		$384 Hold
9
– – ﹤0.01% 3333
2024
Q1 		$384 Hold
9
– – ﹤0.01% 3098
2023
Q4 		$414 Buy
+9
New +$284 ﹤0.01% 3031
2023
Q2 		– Sell
-3,812
Closed -$68K – 2557
2023
Q1 		$68K Hold
3,812
– – 0.02% 518
2022
Q4 		$111K Buy
+3,812
New +$98K 0.04% 303

Other funds holding RYTM

TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's RYTM Position: Q3 2026 in Review

Farther Finance Advisors increased its Rhythm Pharmaceuticals (RYTM) stake by 1.1% in Q3 2026, buying an estimated $747 and bringing the position to 660 shares worth $62.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3222.

Farther Finance Advisors first reported a position in RYTM in Q4 2022 and has held it in 14 quarters since. The position peaked at $111K in Q4 2022. 6 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Farther Finance Advisors held 660 shares of Rhythm Pharmaceuticals worth $62.8K as of Q3 2026.
  • Farther Finance Advisors bought 7 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $747.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3222 holding.
  • Farther Finance Advisors first reported a position in Rhythm Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • Farther Finance Advisors's Rhythm Pharmaceuticals position peaked at $111K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.